.:. Consultation > Par auteur > Amour .:.

1 document

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial Girard N., Mornex F., Douillard J.-Y., Bossard N., Quoix E., Beckendorf V., Grunenwald D., Amour E., Milleron B. Lung Cancer 69(1) (2010) 86-93 [hal-00539239 - version 1]